A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination
Modern Rheumatology Case Reports · 2025
DOI: 10.1093/mrcr/rxaf039 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Ryuhei Ishihara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Immunoglobulin G, COVID-19, BNT162 Vaccine. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
We report a case of a 64-year-old Japanese man who developed IgG4-related pericoronary arteritis following mRNA-based COVID-19 vaccination. The patient presented with anterior chest pain and imaging revealed perivascular soft tissue thickening around the coronary arteries, along with pancreatic enlargement, enlarged prostate, and periaortitis. Laboratory tests showed markedly elevated serum IgG4 levels (1740 mg/dl). Histopathological findings from prostate biopsy were consistent with IgG4-related disease. Notably, retrospective analysis of preserved serum samples demonstrated a sharp increase in IgG4 levels following the third BNT162b2 vaccine dose, suggesting a possible link between vaccination and disease onset. The patient responded to prednisolone, with significant clinical and radiological improvement. However, IgG4 levels rebounded during tapering, requiring additional immunosuppressive therapy with azathioprine and planned rituximab treatment. This case represents the first documented instance tracking longitudinal changes in serum IgG4 levels from prevaccination through disease onset. While a definitive causal relationship between COVID-19 vaccination and IgG4-related disease remains unproven, this case highlights the need for further investigation into the potential immunopathogenic mechanisms involved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Diagnostic Pathology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Public Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Infection Control Science, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
ORCID-Profile: Ryu Watanabe
Zitieren
APA
Ishihara, R., Watanabe, R., Yao, A., Kuwamoto, T., Katsushima, M., Fukumoto, K., Tanaka, S., Kakutani, Y., Shibata, A., Yamada, S., Fukushima, W., Kakeya, H., Shoji, T., Emoto, M., Shimono, T., & Hashimoto, M. (2025). A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxaf039
Vancouver
Ishihara R, Watanabe R, Yao A, Kuwamoto T, Katsushima M, Fukumoto K, et al. A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxaf039
BibTeX
@article{Ishihara2025,
author = {Ishihara, Ryuhei and Watanabe, Ryu and Yao, Ayaka and Kuwamoto, Tomohiro and Katsushima, Masao and Fukumoto, Kazuo and Tanaka, Sayaka and Kakutani, Yoshinori and Shibata, Atsushi and Yamada, Shinsuke and Fukushima, Wakaba and Kakeya, Hiroshi and Shoji, Tetsuo and Emoto, Masanori and Shimono, Taro and Hashimoto, Motomu},
title = {A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination},
journal = {Modern Rheumatology Case Reports},
year = {2025},
doi = {10.1093/mrcr/rxaf039}
}
EUVIMED